FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended March 31, 2001


Commission File Number 1-8635

                          AMERICAN MEDICAL ALERT CORP.
             (Exact Name of Registrant as Specified in its Charter)

         New York                                             11-2571221
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                            Identification Number)

                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No __

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date: 6,415,241 shares of $.01 par
value common stock as of May 14, 2001.


<PAGE>


                           AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY
<TABLE>
<CAPTION>

                                            INDEX                                       PAGE

Part  I  Financial Information

<S>                                                                                           <C>
                  Report of Independent Accountants                                           1

                  Condensed Consolidated Balance Sheets for March 31, 2001
                  and December 31, 2000                                                       2

                  Condensed Consolidated Statements of Income for the

                  Three Months Ended March 31, 2001 and 2000                                  3

                  Condensed Consolidated Statements of Cash Flows for

                  the Three Months Ended March 31, 2001 and 2000                              4

                  Notes to Condensed Consolidated Financial Statements                        6

                  Management's Discussion and Analysis of

                  Financial Condition and Results of Operations                               8

Part II  Other Information                                                                   11
</TABLE>

<PAGE>


Report of Independent Accountants

Board of Directors and Shareholders
American Medical Alert Corp. and Subsidiaries
Oceanside, New York

We have reviewed the condensed consolidated balance sheet of American Medical
Alert Corp. and Subsidiaries as of March 31, 2001 and the related condensed
consolidated statements of income and cash flows for the three-month periods
ended March 31, 2001 and 2000. These financial statements are the responsibility
of the company's management.

We conducted our reviews in accordance with standards established by the
American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical procedures to
financial data and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to the condensed consolidated financial statements referred to above for
them to be in conformity with accounting principles generally accepted in the
United States of America.

We have previously audited, in accordance with auditing standards generally
accepted in the United States of America, the consolidated balance sheet as of
December 31, 2000, and the related consolidated statements of income,
shareholders' equity and cash flows for the year then ended (not presented
herein); and in our report dated April 13, 2001, we expressed an unqualified
opinion on those consolidated financial statements. In our opinion, the
information set forth in the accompanying condensed consolidated balance sheet
as of December 31, 2000 is fairly stated, in all material respects, in relation
to the consolidated balance sheet from which it has been derived.

/s/ Margolin, Winer & Evens LLP

Margolin, Winer & Evens LLP

May 10,  2001

                                      -1-
<PAGE>
<TABLE>
<CAPTION>
                                                  PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.
        ---------------------
                                          AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
                                              CONDENSED CONSOLIDATED BALANCE SHEETS

                                                              ASSETS

                                                                                      March 31, 2001
                                                                                       (Unaudited)            Dec. 31, 2000*
                                                                                   ---------------------    --------------------
<S>                                                                                    <C>                     <C>
    CURRENT ASSETS
         Cash                                                                          $     562,219           $      537,247
         Accounts and notes receivable
         (net of allowance for doubtful accounts of $320,000 and $300,000)                 2,935,534                2,850,756
         Notes and other receivables                                                         201,609                  219,971
         Inventory                                                                           159,314                  154,880
         Prepaid and refundable taxes                                                        575,251                  601,478
         Prepaid expenses and other current assets                                            70,929                   98,859
         Deferred income tax benefit                                                         309,000                  309,000
                                                                                   ---------------------    --------------------
         Total Current Assets                                                              4,813,856                4,772,191
                                                                                   ---------------------    --------------------
    INVENTORY OF MEDICAL DEVICES HELD FOR LEASE - AT COST                                  1,517,747                1,886,016
    FIXED ASSETS                                                                   ---------------------    --------------------
         (Net of accumulated depreciation and amortization)                                6,675,963                6,707,226
                                                                                   ---------------------    --------------------
    OTHER ASSETS
           Long-term portion of notes receivable                                             175,903                  196,428
           Intangible assets and deferred charges
                (net of accumulated amortization of $267,777 and $209,438)                 1,458,382                1,502,375
           Other assets                                                                       71,825                   69,597
                                                                                   ---------------------    --------------------
                                                                                           1,706,110                1,768,400
                                                                                   ---------------------    --------------------
    TOTAL ASSETS                                                                         $14,713,676              $15,133,833
                                                                                   =====================    ====================
    LIABILITIES AND SHAREHOLDERS' EQUITY

    CURRENT LIABILITIES:
         Current portion of long term debt                                               $   228,781             $    247,839
         Accounts payable                                                                  1,011,621                1,077,168
         Accrued expenses                                                                    615,384                  791,053
         Current portion of capital lease obligations                                        183,880                  179,565
         Deferred revenue                                                                     98,048                  163,357
                                                                                   ---------------------    --------------------
         Total Current Liabilities                                                         2,137,714                2,458,983

    DEFERRED INCOME TAX LIABILITY                                                            507,000                  507,000
    LONG-TERM PORTION OF NOTES PAYABLES                                                    2,027,101                2,107,843
    LONG-TERM PORTION OF CAPITAL LEASE OBLIGATIONS                                           357,812                  308,721
    PUT WARRANT OBLIGATION                                                                   209,000                  189,000
    DEFERRED GAIN ON SALE OF EQUIPMENT                                                        10,166                   11,566
                                                                                   ---------------------    --------------------
         TOTAL LIABILITIES                                                                 5,248,793                5,419,756
                                                                                   ---------------------    --------------------

    COMMITMENTS AND CONTINGENT LIABILITIES                                                     -                      -
    SHAREHOLDERS' EQUITY
         Preferred stock, $.01 par value - authorized, 1,000,000 shares; none
         issued and outstanding
         Common stock, $.01 par value - authorized, 10,000,000 shares; issued
         6,459,151 and 6,458,021 shares in 2001 and 2000, respectively.                       64,580                   64,580
         Additional paid-in capital                                                        6,265,939                6,265,939
         Retained earnings                                                                 3,240,396                3,326,233
                                                                                   ---------------------    --------------------
                                                                                           9,570,915                9,656,752
         Less 43,910 shares of treasury stock, at cost                                      (106,032)                (106,032)
                                                                                   ---------------------    --------------------
         Total Shareholders' Equity                                                        9,464,883                9,550,720
                                                                                   ---------------------    --------------------
    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY                                           $14,713,676              $15,133,833
                                                                                   =====================    ====================

See accompanying notes to condensed financial statements.

* Derived from audited financial statements, with a reclassification to conform to March 31, 2001 presentation

                                                               -2-
<PAGE>

                                          AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES
                                           CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                                           (Unaudited)

                                                                                        Three Months Ended March 31,
                                                                                        2001                     2000
                                                                                ---------------------     -------------------
Revenues:
     Services                                                                   $         3,208,413       $         2,389,174
     Product sales                                                                          103,097                    81,430
                                                                                ---------------------     -------------------
                                                                                          3,311,510                 2,470,604
Costs and Expenses (Income):
     Costs related to services                                                            1,694,584                   995,394
     Costs of products sold                                                                  70,174                    53,378
     Selling, general and administrative expenses                                         1,647,221                 1,135,571
     Interest expense                                                                        66,035                    14,307
     Other income                                                                           (32,667)                   (8,912)
                                                                                ---------------------     -------------------

Income (loss) before provision for income taxes                                            (133,837)                  280,866

     Provision (credit) for income taxes                                                    (48,000)                  118,000
                                                                                ---------------------     -------------------

NET INCOME (LOSS)                                                               $           (85,837)      $           162,866
                                                                                =====================     ===================

Net income (loss) per share:

     Basic                                                                      $              (.01)      $               .03
                                                                                ---------------------     -------------------
     Diluted                                                                    $              (.01)      $               .03
                                                                                ---------------------     -------------------

Weighted average number of common shares outstanding (Note 3)
     Basic                                                                                6,415,241                 6,407,057
                                                                                =====================     ===================

     Diluted                                                                              6,415,241                 6,416,524
                                                                                =====================     ===================

See accompanying notes to condensed financial statements.


                                                               -3-
<PAGE>



                                          AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

                                         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                           (Unaudited)

                                                                                          Three Months Ended March 31,
                                                                                         2001                      2000
                                                                                 ---------------------     ---------------------
Cash Flows From Operating Activities:

     Net income (loss)                                                           $           (85,837)      $           162,866

     Adjustments  to  reconcile  net  income  (loss)  to net cash  provided  by
       operating activities
     Depreciation and amortization                                                           490,194                   414,712
     Valuation of put warrants                                                                20,000                         -
     Loss on unrecovered leased medical equipment                                             28,404                    17,795
     Decrease (increase) in:
       Accounts receivables                                                                  (84,778)                 (417,583)
       Inventory                                                                              (4,434)                  (73,629)
        Prepaid and refundable taxes                                                          26,227                         -
       Prepaid expenses and other assets                                                      25,701                   (31,663)
     Increase (decrease) in:
       Accounts payable and accrued expenses                                                (242,616)                  325,382
        Deferred revenue                                                                     (65,309)                        -
                                                                                 ---------------------     ---------------------

Net Cash Provided by Operating Activities                                                    107,552                   397,880
                                                                                 ---------------------     ---------------------

Cash Flows From Investing Activities:
     Expenditures for fixed assets net of utilization of medical devices
      held for lease                                                                          39,663                (1,110,938)
     Increase in notes receivable                                                                  -                  (295,621)
     Repayment of notes receivable                                                            38,888                         -
     Payment for account acquisitions and goodwill                                           (16,396)                 (292,000)
                                                                                 ---------------------     ---------------------

Net Cash Provided by (Used In) by Investing Activities                                        62,155                (1,698,559)
                                                                                 ---------------------     ---------------------

Cash Flows From Financing Activities:
     Increase in notes payable - bank                                                              -                   600,000
     Principal payments under capital lease obligation                                       (44,934)                        -
     Proceeds from (repayments of) loans payable                                              17,898                   (48,579)
     Repayment of notes payable                                                             (117,699)
     Net proceeds upon exercise of stock options                                                   -                    26,306
                                                                                 ---------------------     ---------------------

Net Cash (Used in) Provided by Financing Activities                                         (144,735)                  577,727
                                                                                 ---------------------     ---------------------

See accompanying notes to condensed financial statements.

                                                               -4-
<PAGE>


                                          AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES

                                   CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
                                                           (Unaudited)

                                                                                    Three Months Ended March 31,
                                                                                     2001                     2000
                                                                              --------------------     --------------------

         Net Increase (decrease) in Cash                                      $           24,972       $         (722,952)

         Cash, Beginning of Period                                                       537,247                  953,734
                                                                              --------------------     --------------------

         Cash, End of Period                                                  $          562,219       $          230,782
                                                                              ====================     ==================

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

CASH PAID DURING THE PERIOD FOR INTEREST                                      $          62,014        $          14,308
                                                                              ====================     ==================

CASH PAID DURING THE PERIOD FOR INCOME TAXES                                  $          -             $          59,105
                                                                              ====================     ==================
</TABLE>
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING
 AND FINANCING ACTIVITY:

During 2001 the Company incurred capital lease obligations of $98,340 when it
entered into a lease agreement for new equipment.

See accompanying notes to condensed financial statements.

                                                               -5-
<PAGE>

                  AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARIES


              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)

1.   General:

         These financial statements should be read in conjunction with the
financial statements and notes thereto for the year ended December 31, 2000
included in the Company's Annual Report on Form 10-KSB.

2.   Results of Operations:

         In the opinion of management, the accompanying unaudited condensed
financial statements contain all adjustments (consisting only of normal
recurring accruals) necessary to present fairly the financial position as of
March 31, 2001 and the results of operations and cash flows for the three months
ended March 31, 2001 and 2000.

         The accounting policies used in preparing these financial statements
are the same as those described in the December 31, 2000 financial statements.

         The results of operations for the three months ended March 31, 2001 are
not necessarily indicative of the results to be expected for any other interim
period or for the full year.

3.   Earnings Per Share:

         In February 1997, the Financial Accounting Standards Board issued SFAS
No. 128, "Earnings per Share" which changes the methodology of calculating
earnings per share. SFAS No. 128 requires the disclosure of diluted earnings per
share regardless of its difference from basic earnings per share. The Company
adopted SFAS No. 128 in December 1997. Earnings per share data for the three
months ended March 31, 2001 and 2000 is presented in conformity with this
pronouncement. Due to the net loss for the three months ended March 31, 2001,
the effect of stock options was not considered as it would have been
anti-dilutive.

         The following table is a reconciliation of the numerators and
denominators in computing earnings per share:
<TABLE>
<CAPTION>
                                                             Income                  Shares                Per-Share
                    March 31, 2001                         (Numerator)            (Denominator)             Amounts
                    --------------                       -------------            -------------        ------------
<S>                                                      <C>                         <C>                  <C>
         Basic EPS -
             Loss available to
                  common stockholders                    $     (85,837)              6,415,241            $(.01)
                                                                                                          ======
         Effect of dilutive securities -
             Options and warrants                                   -                       -
                                                         -------------           ------------

                                      -6-
<PAGE>

         Diluted EPS -
             Loss available to common
                  stockholders and
                  assumed conversions                    $     (85,837)              6,415,241            $(.01)
                                                         ==============         ==============            ======

                    March 31, 2000

         Basic EPS -
             Income available to

                  common stockholders                    $     162,866               6,407,057            $.03
                                                                                                          ====

         Effect of dilutive securities -
             Options and warrants                                   -                    9,467
                                                         -------------          --------------

         Diluted EPS -
             Income available to common
                  stockholders and
                  assumed conversions                    $     162,866               6,416,524            $.03
                                                         =============          ==============            ====
</TABLE>

4.       Major Customers:

         The Company provides services to Medicaid home care programs in over
ten states. During the three months ended March 31, 2001 and 2000 the Company
had revenue from the City of New York, Human Resources Administration, Home Care
Services Program ("HCSP") which represented, respectively, 28% and 36% of total
revenue for each period. The contract, which was previously effective through
June 30, 1999, was extended through December 31, 2000. The City of New York has
advised the Company that an extension of the contract, under the same terms and
conditions, is being processed which if executed by the City of New York will
extend the contract through June 30, 2001. In June 1999, the Company submitted
its proposal to HCSP to renew and extend the contract. Since June 30, 1999, the
Company has continued to provide service while awaiting HCSP's selection of a
provider under the new contract. As of May 14, 2001 the City of New York is
still evaluating the subject award. If the Company is chosen to continue to
provide the services and is awarded a new contract, there can be no assurance
that the same level of revenues will be sustained due to a variety of factors
including pricing, number of subscribers to be serviced and the amount of time
that passes before the renewal contract is acted upon by HCSP. Depending upon
how HCSP may award the contract, pricing on an individual subscriber basis may
be lower than current levels. If HCSP does not renew the contract, a significant
amount of the Company's revenue would be lost, which would have a material
adverse effect on operating results, and in addition, there most likely would be
a write-down of the Company's leased medical devices (and/or a reduction in
their remaining useful lives) and medical devices held for lease. The extent and
significance of the write down will be dependent upon the length of the
transition period to the new provider subject to management's ability to place
these devices with other providers. As of March 31, 2001 and December 31, 2000
accounts receivable from the contract represented 54% and 57%, respectively, of
accounts receivable and leased medical devices in service under the contract
represented 29% and 31%, respectively, of leased medical devices.

                                      -7-
<PAGE>

5.      Segment  Reporting:

The Company has two reportable segments, Personal Emergency Response Systems
("PERS") and Telephone After-Hours Answering Services ("TAS"), which is provided
through the Company's HCI subsidiary, which acquired the assets of Harriet
Campbell Inc. on November 21, 2000.

The table below provides a reconciliation of segment information to total
consolidated information for the three months ended March 31, 2001:
<TABLE>
<CAPTION>
                                                   PERS               TAS             Other           Consolidated
                                              ------------      ------------       ------------       ------------
<S>                                           <C>               <C>                <C>                <C>
Revenue                                       $  2,792,344      $    500,537       $     18,629       $  3,311,510
Income (loss) before provision for
income taxes                                    (139,898)             25,585           (19,524)            (133,837)
Total assets                                    12,769,457         1,754,020            190,199           14,713,676
</TABLE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        -----------------------------------------------------------------------
        OF  OPERATIONS.
        ---------------

The following discussion and analysis provides information which management
believes is relevant to an assessment and understanding of the Company's results
of operations and financial condition. The discussion should be read in
conjunction with the consolidated financial statements contained in the latest
Annual Report dated December 31, 2000.

This discussion contains forward-looking statements which, in addition to
assuming a continuation of the degree and timing of customer utilization and
rate of renewals of contracts with the Company at historical levels, are subject
to a number of known and unknown risks that, in addition to general economic,
competitive and other business conditions, could cause actual results,
performance and achievements to differ materially from those described or
implied in the forward-looking statements.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

The Company has an amended $1,700,000 Revolving Credit Facility (the "Facility")
with a bank expiring May 31, 2002 (based upon 75% of eligible accounts
receivable and 50% of inventory, as defined in the agreement with respect to the
Facility). Borrowings under the Facility bear interest at the lower of the prime
rate or the LIBOR Rate plus 2.50% and are collateralized by the Company's
assets. There was $1,300,000 outstanding under the Facility as of March 31, 2001
and May 14, 2001, respectively. The agreement with respect to the Facility
provides for negative and affirmative covenants including those related to
tangible net worth, working capital and other borrowings. At December 31, 2000
there was $1,300,000 outstanding under the Facility.

The Company's working capital on March 31, 2001 was $2,676,142 as compared to
$2,313,142 on December 31, 2000. During 2001, the Company anticipates that it
will make capital

                                      -8-
<PAGE>

investments of approximately $1,500,000 of which approximately $60,000 was
expended during the first quarter.

The Company derives a significant portion of its revenue from one contract with
the City of New York's Human Resources Administration, Home Care Services
Program ("HCSP"). During the three months ended March 31, 2001 and 2000, the
Company had revenue from this contract, which represented 28% and 36%,
respectively, of total revenues for each period. As of March 31, 2001 and
December 31, 2000, accounts receivable from the contract represented 54% and
57%, respectively, of accounts receivable. Leased medical devices in service
relating to this contract represented 29% and 31%, respectively, of total leased
medical devices at March 31, 2001 and December 31, 2000. Inventory relating to
this contract represented approximately 15% of total inventory on hand at March
31, 2001 and December 31, 2000. The contract with HCSP originally expired on
June 30, 1999. In January 1999, the Company and several other companies
submitted proposals to the City of New York to be awarded a new contract through
June 30, 2003.

On October 22, 1999, the Company was advised by HCSP that another company had
been preliminarily recommended. The Company's management reviewed HCSP's
preliminary recommendation and assessed alternative options and courses of
action. On November 1, 1999, the Company submitted a formal protest pursuant to
paragraph 4-04 of the Rules of the Procurement Policy Board of the City of New
York to contest the preliminary award. While the protest was ultimately denied,
as of May 14, 2001, the contract had not been awarded. In the meantime, the
Company continues to service it customers under the terms of the expired
contract through various retroactive extensions granted by the City of New York,
the last of which was through December 31, 2000.  The City of New York has
advised the Company that an extension of the contract, under the same terms and
conditions, is being processed which if executed by the City of New York will
extend the contract through June 30, 2001.

If the City of New York HCSP awards the contract to another vendor, a
significant amount of the Company's revenues would be lost, having a material
adverse effect on operating results. With the potential loss of approximately
28% of the Company's revenues, cash flow from operations would be adversely
affected. In addition, it is possible that significant adjustments to inventory
and fixed assets associated with the contract would occur. It could be expected
that revenues from HCSP would continue on a diminishing scale until all units
are removed and management is prepared to eliminate significant personnel costs
and fixed overhead associated with servicing the contract. The Company cannot
assess the full financial impact at this time, as no determination can be made
on how the transition to another vendor would be accomplished, and in what time
frame the transition will be made.

In light of the possibility that the Company's contract with HCSP may not be
renewed, the Company's management has developed and implemented a business plan
to minimize the potential loss through reduction in HCSP related overhead and
the re-deployment of assets to other programs. In addition, the Company focuses
on, and will continue to build its subscriber base through consumers, healthcare
agencies, health maintenance organizations, durable medical equipment providers,
retirement communities, hospitals and other governmental agencies. In addition,
the Company is continuing to invest in new products, services and initiatives.

                                      -9-
<PAGE>

RESULTS OF OPERATIONS
---------------------

Revenue from services, MRR, increased by $819,239 for the three months ended
March 31, 2001 as compared to the same period in 2000, an increase of 34%. For
the three months ended March 31, 2001 the Company recorded revenues of
approximately $500,000 from its wholly owned subsidiary, HCI Acquisition Corp.
("HCI"), which acquired the assets of Harriet Campbell Inc. in November 2000.
The Company has experienced continued success in growing its customer base
outside the contract with the City of New York through a variety of marketing
efforts that have continued to contribute to increasing MRR. These efforts
include expansion into new regions, competitive conversions, strategic
partnerships with healthcare provider systems, and additional entry into
Medicaid reimbursed marketplaces.

Costs related to services increased by $699,190 for the three months ended March
31, 2001 as compared to the same period in 2000, an increase of 70%. Costs
related to services, as a percentage of service revenues, for the three months
ended March 31, 2001 and 2000 were 53% and 42%, respectively. For the three
months ended March 31, 2001 the Company recorded costs related to services of
approximately $223,000 from HCI. The costs related to services increased due to
employing additional response center personnel, additional depreciation and
amortization expenses, and certain fixed and variable production costs being
expensed as a result of the limited production during the three months ended
March 31, 2001. Such limited production resulted from the Company's utilization
of its leased medical devices held as inventory for lease as of December 31,
2000.

Selling, general and administrative expenses increased by $511,650 for the three
months ended March 31, 2001 as compared to the same period in 2000, an increase
of 45%. Selling, general, and administrative expenses, as a percentage of total
revenue, for the three months ended March 31, 2001 and 2000 were 50% and 46%,
respectively. For the three months ended March 31, 2001 the Company recorded
selling, general and administrative expenses of approximately $242,000 from HCI.
Additional expenses were the result of increased legal and accounting fees in
the amount of approximately $150,000 incurred in 2001, as well as the continued
employment of additional executive and management personnel.

Interest expense increased by $51,728 for the three months ended March 31, 2001
as compared to the same period in 2000. Interest expense increased due to
additional borrowings throughout 2000 needed to fund increased production of
units and equipment needs for new subscribers, fund management systems, and the
acquisition by HCI of the assets of Harriet Campbell Inc. Such additional
borrowings were not outstanding for the three months ended March 31, 2000 but
were outstanding as of March 31, 2001.

The Company's loss before provision for income taxes for the three months ended
March 31, 2001 was $133,837 as compared to a profit of $280,866 for the same
period in 2000. The decrease in profit of $414,703 resulted from an increase in
the Company's costs related to services and selling, general and administrative
costs, offset by an increase in service revenues.

                                      -10-
<PAGE>

                           PART II - OTHER INFORMATION

ITEM 3.    LEGAL PROCEEDINGS.
           ------------------

Although the Company is a party to certain routine litigation incidental to its
business, the Company believes that, except as set forth below, there are no
material pending legal proceedings to which it is a party or to which any of its
properties are subject.

On March 2, 2001 American Medical Alert Corp. was served with a Summons and
Complaint by a former employee seeking to recover damages for discrimination and
harassment in connection with her employment and the alleged termination
thereof. The action is pending in the Supreme Court of Queens County. The
plaintiff seeks to recover the sum of $750,000 for compensatory damages and
$750,000 for punitive damages. Attorneys representing the Company believe that
American Medical Alert Corp. has meritorious defenses to the complaint. Counsel
has further concluded that the likelihood of success by the Plaintiff on the
causes of action and relief demanded in the complaint is remote. At the present
time the insurance company has declined coverage although efforts to obtain a
reversal of the declination of coverage are ongoing.

ITEM 6. EXHIBIT AND REPORTS ON FORM 8-K.
        --------------------------------

(a)  Exhibits:


         None.


(b)  Reports on Form 8-K:


         No reports on Form 8-K were filed.


                                      -11-
<PAGE>

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.

                                          AMERICAN MEDICAL ALERT CORP.

Dated:  May 15, 2001                      By: /s/ Howard M. Siegel
                                             -----------------------------------
                                             Name:  Howard M. Siegel
                                             Title: Chairman of the Board
                                                    and President

                                          By: /s/ Richard Rallo
                                             -----------------------------------
                                             Name:  Richard Rallo
                                             Title: Controller

                                      -12-